KA
GSK icon

Kovack Advisors’s GSK GSK Stock Holding History

Kovack Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11
Closed -$16K – 224
2015
Q1 		$16K Buy
+11
New +$631 0.01% 170

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Kovack Advisors's GSK Position: Q1 2026 in Review

Kovack Advisors reduced its GSK (GSK) stake by 0.29% in Q1 2026, selling an estimated $921 and leaving 5,793 shares worth $322K. The position accounts for 0.02% of the portfolio, ranked #733.

Kovack Advisors first reported a position in GSK in Q1 2015 and has held it in 38 quarters since. The position peaked at $985K in Q3 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Kovack Advisors held 5,793 shares of GSK worth $322K as of Q1 2026.
  • Kovack Advisors sold 17 GSK shares in Q1 2026, an estimated $921.
  • GSK made up 0.02% of Kovack Advisors's portfolio in Q1 2026, its #733 holding.
  • Kovack Advisors first reported a position in GSK in Q1 2015 and has held it in 38 quarters since.
  • Kovack Advisors's GSK position peaked at $985K in Q3 2016.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.